Tenet Healthcare Corporation
US ˙ NYSE ˙ US88033G4073

SecurityTHC / Tenet Healthcare Corporation
InsiderMeghan Fitzgerald
This page shows the track record and history of Fitzgerald Meghan insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Meghan Fitzgerald in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-03-17 6,153 13.0200 6,153 13.0200 80,112 363 57.5600 274,055 342.09

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Meghan Fitzgerald in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-08-06 20,000 146.3400 20,000 146.3400 2,926,800 258 110.4100 -718,600 -24.55
2021-09-16 6,077 72.7000 6,077 72.7000 441,798
2021-05-24 6,153 63.5700 6,153 63.5700 391,146

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-26 2026-05-22 4 Fitzgerald Meghan THC Common Stock D - Sale to Issuer D 173.7800 -493 -86 17,087
2026-05-26 2026-05-22 4 Fitzgerald Meghan THC Common Stock M - Exercise D 1,333 17,580
2025-05-27 2025-05-23 4 Fitzgerald Meghan THC Common Stock D - Sale to Issuer D 161.3300 -573 -92 16,247
2025-05-27 2025-05-23 4 Fitzgerald Meghan THC Common Stock M - Exercise D 1,551 16,820
2024-08-08 2024-08-06 4 Fitzgerald Meghan THC Common Stock S - Sale D 146.3400 -20,000 -2,927 15,269
2023-06-23 2023-05-26 4/A Fitzgerald Meghan THC Common Stock A - Award D 3,682 35,269
2023-05-30 2023-05-26 4 Fitzgerald Meghan THC Common Stock A - Award D 2,846 34,433
2022-05-11 2022-05-09 4 Fitzgerald Meghan THC Common Stock A - Award D 3,836 31,587
2021-09-20 2021-09-16 4 Fitzgerald Meghan THC Common Stock S - Sale D 72.7000 -6,077 -442 27,751
2021-05-26 2021-05-24 4 Fitzgerald Meghan THC Common Stock S - Sale D 63.5700 -6,153 -391 33,828
2021-05-11 2021-05-07 4 Fitzgerald Meghan THC Common Stock A - Award D 3,960 39,981
2020-06-02 2020-05-29 4 Fitzgerald Meghan THC Common Stock A - Award D 11,139 36,021
2020-03-18 2020-03-17 4 Fitzgerald Meghan THC Common Stock P - Purchase D 13.0200 6,153 80 24,882
2019-05-07 2019-05-03 4 Fitzgerald Meghan THC Common Stock A - Award D 10,817 18,729
2018-06-04 2018-05-31 4 Fitzgerald Meghan THC Common Stock A - Award D 7,912 7,912
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)